These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35225476)

  • 1. Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study.
    Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Dhamne C; Blair S; Lam C; Rujkijyanont P; Traivaree C; Photia A; Veerapan P; Puhaindran ME; Oh BLZ; Wang E; Rodriguez-Galindo C
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):631-640. PubMed ID: 35225476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
    Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
    Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy.
    Hegyi M; Semsei AF; Jakab Z; Antal I; Kiss J; Szendroi M; Csoka M; Kovacs G
    Pediatr Blood Cancer; 2011 Sep; 57(3):415-22. PubMed ID: 21563300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of the treatment of pediatric osteosarcoma in the Hungarian population].
    Hegyi M; Félné Semsei A; Jakab Z; Antal I; Kiss J; Szendrõi M; Csóka M; Kovács G
    Magy Onkol; 2012 Mar; 56(1):30-7. PubMed ID: 22403760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study.
    Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Kimpo M; Dhamne C; Blair S; Lam C; Photia A; Rujkijyanont P; Traivaree C; Pairojboriboon S; Rodriguez-Galindo C;
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29556. PubMed ID: 35038209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and outcomes for osteosarcoma: an international collaboration.
    Pakos EE; Nearchou AD; Grimer RJ; Koumoullis HD; Abudu A; Bramer JA; Jeys LM; Franchi A; Scoccianti G; Campanacci D; Capanna R; Aparicio J; Tabone MD; Holzer G; Abdolvahab F; Funovics P; Dominkus M; Ilhan I; Berrak SG; Patino-Garcia A; Sierrasesumaga L; San-Julian M; Garraus M; Petrilli AS; Filho RJ; Macedo CR; Alves MT; Seiwerth S; Nagarajan R; Cripe TP; Ioannidis JP
    Eur J Cancer; 2009 Sep; 45(13):2367-75. PubMed ID: 19349163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
    Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
    Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
    Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
    J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic fracture does not influence prognosis in stage IIB osteosarcoma: a case-control study.
    Zuo D; Zheng L; Sun W; Hua Y; Cai Z
    World J Surg Oncol; 2013 Jun; 11():148. PubMed ID: 23799947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oncological and functional outcomes in Lower-limb osteosarcoma pediatric patients: a large single-center retrospective cohort study.
    Xu M; Tu J; Huang Y; Wang B; Zhao Z; Lin T; Huang G; Yin J; Xie X; Shen J; Zou C
    Int J Surg; 2024 Jul; 110(7):4208-4220. PubMed ID: 38471042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis.
    Papakonstantinou E; Athanasiadou KI; Markozannes G; Tzotzola V; Bouka E; Baka M; Moschovi M; Polychronopoulou S; Hatzipantelis E; Galani V; Stefanaki K; Strantzia K; Vousvouki M; Kourou P; Magkou E; Nikita M; Zambakides C; Michelarakis J; Alexopoulou A; Gavra M; Malama A; Ntzani EE; Petridou ET
    Cancer Epidemiol; 2024 Jun; 90():102551. PubMed ID: 38447251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and Survival of Patients with Osteosarcoma After Limb Salvage versus Amputation: A Population-Based Analysis with Propensity Score Matching.
    Qi L; Ren X; Liu Z; Li S; Zhang W; Chen R; Chen C; Tu C; Li Z
    World J Surg; 2020 Jul; 44(7):2201-2210. PubMed ID: 32170370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L; Deng S; Zhang F; Liang Y; Huang Z
    World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
    Choeyprasert W; Natesirinilkul R; Charoenkwan P; Sittipreechacharn S
    Asian Pac J Cancer Prev; 2013; 14(2):1101-6. PubMed ID: 23621194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcomes and prognostic factors of non-metastatic radiation-induced sarcoma of bone.
    Tsuda Y; Lowe M; Evans S; Parry MC; Stevenson JD; Fujiwara T; Kaneuchi Y; Le Nail LR; Jeys LM
    Eur J Surg Oncol; 2020 Feb; 46(2):293-298. PubMed ID: 31703834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
    Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
    Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
    Abou Ali B; Salman M; Ghanem KM; Boulos F; Haidar R; Saghieh S; Akel S; Muwakkit SA; El-Solh H; Saab R; Tamim H; Abboud MR
    J Glob Oncol; 2019 Apr; 5():1-8. PubMed ID: 30946633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
    Bajpai J; Chandrasekharan A; Talreja V; Simha V; Chandrakanth MV; Rekhi B; Khurana S; Khan A; Vora T; Ghosh J; Banavali SD; Gupta S
    Eur J Cancer; 2017 Nov; 85():49-58. PubMed ID: 28888849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.